Because ADK progressively increases in line with epilepsy development and progression (Li et al., 2007a), and because epileptogenic activity originates from ADK-expressing brain areas (Li et al. 2008; Li et al. 2012), ADK is a biomarker to identify epileptogenic brain areas and to monitor epileptogenesis longitudinally. The gene discussed is ADK; the disease is epilepsy.